New screening methods could change how we detect prostate cancer
NCT ID NCT07155759
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study follows 7,500 men aged 50-74 to see if using a combination of PSA, a biomarker test, and MRI leads to better long-term outcomes, including fewer deaths from prostate cancer. Participants were invited for screening and compared to those who had standard PSA testing or no organized screening. The goal is to find out which approach best detects dangerous cancers while avoiding unnecessary biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska Institutet
Stockholm, Sweden
Conditions
Explore the condition pages connected to this study.